Q1 Earnings Estimate for Beam Therapeutics Issued By Wedbush
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Equities research analysts at Wedbush upped their Q1 2025 earnings per share estimates for Beam Therapeutics in a research note issued on Monday, March 10th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of ($1.00) for the quarter, up from their […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Equities research analysts at Wedbush upped their Q1 2025 earnings per share estimates for Beam Therapeutics in a research note issued on Monday, March 10th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of ($1.00) for the quarter, up from their […]
